|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI
|
|
2
|
Li T, Mello-Thoms C and Brennan PC:
Descriptive epidemiology of breast cancer in China: Incidence,
mortality, survival and prevalence. Breast Cancer Res Treat.
159:395–406. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liyanage PY, Hettiarachchi SD, Zhou Y,
Ouhtit A, Seven ES, Oztan CY, Celik E and Leblanc RM:
Nanoparticle-mediated targeted drug delivery for breast cancer
treatment. Biochim Biophys Acta Rev Cancer. 1871:419–433. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tan C, Hu W, He Y, Zhang Y, Zhang G, Xu Y
and Tang J: Cytokine-mediated therapeutic resistance in breast
cancer. Cytokine. 108:151–159. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nalio Ramos R, Missolo-Koussou Y,
Gerber-Ferder Y, Bromley CP, Bugatti M, Núñez NG, Tosello Boari J,
Richer W, Menger L, Denizeau J, et al: Tissue-resident
FOLR2+ macrophages associate with CD8+ T cell
infiltration in human breast cancer. Cell. 185:1189–1207.e25. 2022.
View Article : Google Scholar
|
|
6
|
Pan Y, Yu Y, Wang X and Zhang T:
Tumor-associated macrophages in tumor immunity. Front Immunol.
11:5830842020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rahal OM, Wolfe AR, Mandal PK, Larson R,
Tin S, Jimenez C, Zhang D, Horton J, Reuben JM, McMurray JS and
Woodward WA: Blocking Interleukin (IL)4- and IL13-mediated
phosphorylation of STAT6 (Tyr641) decreases M2 polarization of
macrophages and protects against macrophage-mediated
radioresistance of inflammatory breast cancer. Int J Radiat Oncol
Biol Phys. 100:1034–1043. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Finkler A, Ashery-Padan R and Fromm H:
CAMTAs: Calmodulin-binding transcription activators from plants to
human. FEBS Lett. 581:3893–3898. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nagase T, Ishikawa K, Suyama M, Kikuno R,
Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nomura N and Ohara O:
Prediction of the coding sequences of unidentified human genes.
XIII. The complete sequences of 100 new cDNA clones from brain
which code for large proteins in vitro. DNA Res. 6:63–70. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Henrich KO, Claas A, Praml C, Benner A,
Mollenhauer J, Poustka A, Schwab M and Westermann F: Allelic
variants of CAMTA1 and FLJ10737 within a commonly deleted region at
1p36 in neuroblastoma. Eur J Cancer. 43:607–616. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pan R, Zhang Z, Jia H, Ma J, Wu C, Xue P,
Cai W, Zhang X and Sun J: CAMTA1-PPP3CA-NFATc4 multi-protein
complex mediates the resistance of colorectal cancer to
oxaliplatin. Cell Death Discov. 8:1292022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Drilon A, Somwar R, Mangatt BP, Edgren H,
Desmeules P, Ruusulehto A, Smith RS, Delasos L, Vojnic M,
Plodkowski AJ, et al: Response to ERBB3-directed targeted therapy
in NRG1-rearranged cancers. Cancer Discov. 8:686–695. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jonna S, Feldman RA, Swensen J, Gatalica
Z, Korn WM, Borghaei H, Ma PC, Nieva JJ, Spira AI, Vanderwalde AM,
et al: Detection of NRG1 gene fusions in solid tumors. Clin Cancer
Res. 25:4966–6972. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yun S, Koh J, Nam SK, Park JO, Lee SM, Lee
K, Lee KS, Ahn SH, Park DJ, Kim HH, et al: Clinical significance of
overexpression of NRG1 and its receptors, HER3 and HER4, in gastric
cancer patients. Gastric Cancer. 21:225–236. 2018. View Article : Google Scholar
|
|
15
|
Shu L, Chen A, Li L, Yao L, He Y, Xu J, Gu
W, Li Q, Wang K, Zhang T and Liu G: NRG1 regulates Fra-1
transcription and metastasis of triple-negative breast cancer cells
via the c-Myc ubiquitination as manipulated by ERK1/2-mediated
Fbxw7 phosphorylation. Oncogene. 41:907–919. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yi C, Wu S, Duan Q, Liu L, Li L, Luo Y and
Wang A: Ferroptosis-dependent breast cancer cell-derived exosomes
inhibit migration and invasion of breast cancer cells by
suppressing M2 macrophage polarization. PeerJ. 11:e150602023.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu C, Huang X, Li S, Ji W, Luo T, Liang J
and Lv Y: M2 macrophage-derived exosomes reverse TGF-β1-induced
epithelial mesenchymal transformation in BEAS-2B cells via the
TGF-βRI/Smad2/3 signaling pathway. Eur J Med Res. 30:2712025.
View Article : Google Scholar
|
|
18
|
Lu F, Ye M, Shen Y, Xu Y, Hu C, Chen J, Yu
P, Xue B, Gu D, Xu L, et al: Hypoxic tumor-derived exosomal
miR-4488 induces macrophage M2 polarization to promote liver
metastasis of pancreatic neuroendocrine neoplasm through RTN3/FABP5
mediated fatty acid oxidation. Int J Biol Sci. 20:3201–3218. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang Y, Li CW, Chan LC, Wei Y, Hsu JM, Xia
W, Cha JH, Hou J, Hsu JL, Sun L and Hung MC: Exosomal PD-L1 harbors
active defense function to suppress T cell killing of breast cancer
cells and promote tumor growth. Cell Res. 28:862–864. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hansen MR, Roehm PC, Chatterjee P and
Green SH: Constitutive neuregulin-1/ErbB signaling contributes to
human vestibular schwannoma proliferation. Glia. 53:593–600. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang Y, Wu T, Wang Y, Luo D, Zhao Z, Sun
H, Zhang M, Zhang B and Han B: Hypoxic tumour-derived exosomal
miR-1290 exacerbates the suppression of CD8+ T cells by promoting
M2 macrophage polarization. Immunology. 173:672–688. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Zhang J, Shi H, Wang M, Yu D, Fu
M, Qian Y, Zhang X, Ji R, Wang S, et al: M2 Tumor-associated
macrophages-derived exosomal MALAT1 promotes glycolysis and gastric
cancer progression. Adv Sci (Weinh). 11:e23092982024. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Ye M, Lu F, Gu D, Xue B, Xu L, Hu C, Chen
J, Yu P, Zheng H, Gao Y, et al: Hypoxia exosome derived CEACAM5
promotes tumor-associated macrophages M2 polarization to accelerate
pancreatic neuroendocrine tumors metastasis via MMP9. FASEB J.
38:e237622024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo M, Wang R, Nie M, Zhang H, Wang C,
Song C and Niu S: H3K27ac-induced RHOXF2 activates Wnt2/β-catenin
pathway by binding to HOXC13 to aggravate the malignant progression
of triple negative breast cancer. Cell Signal. 120:1111962024.
View Article : Google Scholar
|
|
26
|
Jiang D, Gao X, Tan R, Liu X, Zhu Y and
Zhang L: Euphorbia factor L1 suppresses breast cancer liver
metastasis via DDR1-mediated immune infiltration. Aging.
15:9217–9229. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schito L and Semenza GL: Hypoxia-inducible
factors: Master regulators of cancer progression. Trends Cancer.
2:758–770. 2016. View Article : Google Scholar
|
|
28
|
King HW, Michael MZ and Gleadle JM:
Hypoxic enhancement of exosome release by breast cancer cells. BMC
Cancer. 12:4212012. View Article : Google Scholar :
|
|
29
|
Yang Y, Jin X, Xie Y, Ning C, Ai Y, Wei H,
Xu X, Ge X, Yi T, Huang Q, et al: The CEBPB+
glioblastoma subcluster specifically drives the formation of M2
tumor-associated macrophages to promote malignancy growth.
Theranostics. 14:4107–4126. 2024. View Article : Google Scholar
|
|
30
|
Sun Y, Lian Y, Mei X, Xia J, Feng L, Gao
J, Xu H, Zhang X, Yang H, Hao X and Feng Y: Cinobufagin inhibits
M2-like tumor-associated macrophage polarization to attenuate the
invasion and migration of lung cancer cells. Int J Oncol.
65:1022024. View Article : Google Scholar
|
|
31
|
Jiang Z, Zhang Y, Zhang Y, Jia Z, Zhang Z
and Yang J: Cancer derived exosomes induce macrophages
immunosuppressive polarization to promote bladder cancer
progression. Cell Commun Signal. 19:932021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang X, Zhou Y, Dong K, Zhang H, Gong J
and Wang S: Exosomal lncRNA HMMR-AS1 mediates macrophage
polarization through miR-147a/ARID3A axis under hypoxia and affects
the progression of hepatocellular carcinoma. Environ Toxicol.
37:1357–1372. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hao C, Sheng Z, Wang W, Feng R, Zheng Y,
Xiao Q and Zhang B: Tumor-derived exosomal miR-148b-3p mediates M2
macrophage polarization via TSC2/mTORC1 to promote breast cancer
migration and invasion. Thorac Cancer. 14:1477–1491. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schraivogel D, Weinmann L, Beier D,
Tabatabai G, Eichner A, Zhu JY, Anton M, Sixt M, Weller M, Beier CP
and Meister G: CAMTA1 is a novel tumour suppressor regulated by
miR-9/9* in glioblastoma stem cells. EMBO J. 30:4309–4322. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shi DM, Li LX, Bian XY, Shi XJ, Lu LL,
Zhou HX, Pan TJ, Zhou J, Fan J and Wu WZ: miR-296-5p suppresses EMT
of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3
signaling. J Exp Clin Cancer Res. 37:2942018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang TT, Qu N, Sun GH, Zhang L, Wang YJ,
Mu XM, Wei WJ, Wang YL, Wang Y, Ji QH, et al: NRG1 regulates redox
homeostasis via NRF2 in papillary thyroid cancer. Int J Oncol.
53:685–693. 2018.PubMed/NCBI
|
|
37
|
Alizadeh A, Santhosh KT, Kataria H, Gounni
AS and Karimi-Abdolrezaee S: Neuregulin-1 elicits a regulatory
immune response following traumatic spinal cord injury. J
Neuroinflammation. 15:532018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ma Y, Fan P, Zhao R, Zhang Y, Wang X and
Cui W: Neuregulin-1 regulates the conversion of M1/M2 microglia
phenotype via ErbB4-dependent inhibition of the NF-κB pathway. Mol
Biol Rep. 49:3975–3986. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen X, Wan Z, Yang L, Song S, Fu Z, Tang
K, Chen L and Song Y: Exosomes derived from reparative M2-like
macrophages prevent bone loss in murine periodontitis models via
IL-10 mRNA. J Nanobiotechnol. 20:1102022. View Article : Google Scholar
|